HIGHLIGHTS
- who: Lymphoblastic Leukemia from the Institut de Recherches Internationales Servier, Suresnes, France, Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York. , Universitu00e9 de Paris, Inserm, UMRS-1144, Optimisation Thu00e9rapeutique en Neuropsychopharmacologie, Paris, France. have published the Article: OPEN ACCESS, in the Journal: (JOURNAL) of 08/04/2023
- what: The aim of this study is to develop a mechanistic model to characterize the complex interplay between UCART19, host lymphocytes, IL7 concentrations, and lymphodepleting agents. The mechanistic part of the model is not designed to account for the absence of dose . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.